Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00970047 · ClinicalTrials.gov registry record
Development of a Fetal Sex Assay From Maternal Whole Blood
A clinical trial of Fetal Sex Determination, sponsored by Sequenom.
- Completed
- Registry status
- 500
- Enrollment target
- 3
- Study locations
NCT00970047: Completed study of Fetal Sex Determination, sponsored by Sequenom.
NCT00970047 is a study of Fetal Sex Determination that has completed, run by Sequenom. The registered enrollment target is 500 participants. The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00970047, a study of Fetal Sex Determination, has completed, sponsored by Sequenom.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
- 3
- Study locations
Study Summary
Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.
Conditions Studied
Study Locations (3)
California
- NCOG Medical Group - San Diego
- IGO - San Diego
- Scripps Clinic Medial Group - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2008-06 |
| Est. Completion | 2010-07 |
What the finished NCT00970047 record still lists
NCT00970047 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Fetal Sex Determination appearing as the primary indexed condition, and to 0 interventions.
NCT00970047 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00970047 about?
NCT00970047 is a clinical study titled "Development of a Fetal Sex Assay From Maternal Whole Blood". Whole blood from pregnant women will be collected to develop a noninvasive fetal sex test.
What is the current status of trial NCT00970047?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2008-06. Estimated completion is 2010-07.
What conditions does trial NCT00970047 study?
This clinical trial studies the following conditions: Fetal Sex Determination.
Who is sponsoring clinical trial NCT00970047?
This trial is sponsored by Sequenom, which has 26 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00970047 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fetal Sex Determination
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia